Dr. Sarkawt Hamad | Heat Treatment | Best Researcher Award
Head of Scientific Development at University Hospital of Cologne, Germany.
Dr. Sarkawt Hamad is a leading researcher specializing in cardiac tissue engineeringย and stem cell technology ๐งฌ. He is currently the Head of Scientific Development at the Marga-and-Walter-Boll-Laboratory, University of Cologne. With a passion for interdisciplinary health sciences ๐, Dr. Hamad has made groundbreaking contributions to regenerative medicine and cell replacement therapies ๐งช. His professional journey reflects his dedication to bridging basic science ๐งซ and clinical applications ๐ฉบ, positioning him as a visionary leader in his field ๐.
Professional Profiles
Education 
Dr. Hamad earned his Ph.D. in Interdisciplinary Health Sciences ๐ง at the University of Cologne ๐ฉ๐ช (2020), achieving magna cum laude ๐ under Dr. Kurt Pfannkucheโs supervision. He completed his master’s in animal physiology ๐ฆด at Salahaddin University ๐ฎ๐ถ (2013), guided by Professor Dr. Ismail Maulood. His academic journey began with a bachelorโs in biology ๐งฌ (2007) and a baccalaureate of science ๐ from Rwandz High School in Kurdistan (2003). Dr. Hamadโs education highlights his commitment to academic excellence ๐, laying the foundation for his contributions to cardiac tissue engineering โค๏ธ.
Professional Experience
Dr. Hamadโs career includes serving as Head of Scientific Development ๐ข at the University of Cologne ๐ฉ๐ช (2025โpresent). He was a PostDoc research fellow ๐งช (2020โ2025) and held a postdoctoral fellowship offer from Harvard Medical School ๐บ๐ธ (2024). Earlier roles include scientist ๐งซ and assistant scientist (2017โ2020) at the University of Cologne, and lecturer/researcher ๐ (2013โ2016) at Soran University ๐ฎ๐ถ. He also managed private businesses ๐๏ธ in education and accounting during 2007โ2010. His diverse professional journey blends research, teaching, and leadership ๐.
Research Focus ๐
Dr. Hamadโs research focuses on cardiac tissue engineering, human iPS cell-derived organoids ๐งฌ, and stem cell signaling pathways ๐. His work involves creating scalable cell culture systems for clinical applications ๐ฅ. Integrating advanced bioengineering ๐งช and regenerative medicine, he addresses challenges in treating heart diseases. His interdisciplinary approach combines biology ๐งซ, physiology ๐ฆด, and engineering ๐ง, fostering innovative solutions for healthcare ๐ฉบ.
Awards and Honors
Dr. Hamadโs accolades include the “Science Talent for Future” grant in 2023 ๐ and the Great Initiative Mind Award ๐ at the Dubai Stem Cell Congress ๐ฆ๐ช in 2024. In 2025, he was honored for his role in developing stem cell and regenerative medicine guidelines ๐ฉบ. These recognitions reflect his contributions to global health ๐ and groundbreaking advancements in regenerative medicine ๐งช.
Conclusion